This article is more than 5 years old. Information may no longer be current.
IOP outcomes may not be affected by postop steroids after combined cataract, trabecular micro-bypass surgery
Click Here to Manage Email Alerts
CORONADO, Calif. — The use of steroids after trabecular micro-bypass stent surgery and concomitant cataract surgery may not cause negative IOP and medication use outcomes, according to a presentation here.
In a poster presented at the American Glaucoma Society meeting, Aaron Winter, MD, and colleagues compared the outcomes of open-angle glaucoma patients who received a trabecular micro-bypass stent and underwent cataract surgery. Postoperatively, 52 patients received topical antibiotics and NSAIDs for 1 week and 4 weeks and 52 patients received topical steroids for 4 weeks.
Baseline IOP for the NSAID group was 16.1 ± 3.9 mm Hg and significantly decreased to 13.5 ± 2.9 mm Hg at 6 months. Baseline IOP for the steroid group was 16.4 ± 5.1 mm Hg and decreased significantly to 14.1 ± 4.3 mm Hg at 6 months. Both decreases were statistically significant (P < .01).
The steroid group had nine cases of IOP spikes in the early postoperative period compared with three cases in the NSAID group.
The mean number of medications decreased from 2.5 ± 1.3 at baseline to 0.5 ± 1.0 at 6 months in the NSAID group and from 2.4 ± 1.3 to 0.8 ± 1.0 in the steroid group (P < .01 for both). – by Kristie L. Kahl and Patricia Nale, ELS
Disclosure: The authors report no relevant financial disclosures.